BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1367@pharmaconomics
DTSTAMP:20260707T015841Z
DTSTART;VALUE=DATE:20260120
DTEND;VALUE=DATE:20260121
SUMMARY:TLX PDUFA — Illuccix
DESCRIPTION:The FDA's approval decision on Illuccix for prostate cancer imaging is due Jan 20\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/2007191/000200719126000004/chinapr.htm\n\nTrack it: https://pharmaconomics.com/e/1367
URL:https://pharmaconomics.com/e/1367
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:TLX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR